Dachaigh › Galar Ae Steatotic › Louisiana

Sgrùdaidhean clionaigeach Galar Ae Steatotic ann an Louisiana

Tha 11 sgrùdaidhean airson Galar Ae Steatotic a’ lorg phàirtichean aig làraichean ann an Louisiana.

Bailtean ann an Louisiana

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Lafayette
89bio Clinical Study Site, Lake Charles
89bio Clinical Study Site, West Monroe

A’ fastadhÌre 3

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Covington
89bio Clinical Study Site, Houma
89bio Clinical Study Site, Lake Charles
agus 2 a bharrachd

A’ fastadhÌre 3

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Tandem Clinical Research, Plaza II, Metairie

A’ fastadhÌre 2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Tandem Clinical Research, Metairie

A’ fastadhÌre 2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Delta Research Partners of Bastrop, LLC, Bastrop
Tandem Clinical Research, Marrero
Care Access - New Iberia, New Iberia
agus 2 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Bastrop
Akero Clinical Study Site, Covington
Akero Clinical Study Site, Houma
agus 5 a bharrachd

A’ fastadhÌre 3

Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Marrero

A’ fastadhÌre 3

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Tandem Clinical Research, Covington
Tandem Clinical Research, Houma
Tandem Clinical Research GI, LLC, Marrero
agus 4 a bharrachd

A’ fastadhÌre 2

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Marrero

A’ fastadhÌre 2

Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Bastrop
GSK Investigational Site, Marrero

A’ fastadhÌre 3

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Tandem Clinical Research, Marrero

A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain

Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT05648214

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.